ClinicalTrials.gov
public full text
Public Domain
B Cell Differentiation in MS
Interventional study with minimal risks and constraints, prospective, monocentric.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL#827975
- Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell#994963
- Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL#810381
- Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy#274395
- R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma#811038
Record · ID 1093318
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive